4/2
09:01 am
anvs
Annovis Bio, Inc. (NYSE: ANVS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Medium
Report
Annovis Bio, Inc. (NYSE: ANVS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
4/2
07:39 am
anvs
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
High
Report
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
4/2
07:30 am
anvs
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results
High
Report
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results
4/1
08:19 am
anvs
Annovis Announces Publication That Supports Understanding of Buntanetap's Mechanism of Action in Humans [Yahoo! Finance]
Low
Report
Annovis Announces Publication That Supports Understanding of Buntanetap's Mechanism of Action in Humans [Yahoo! Finance]
4/1
08:00 am
anvs
Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in Humans
Low
Report
Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in Humans
3/21
11:34 am
anvs
Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 211.71%: Read This Before Placing a Bet [Yahoo! Finance]
Low
Report
Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 211.71%: Read This Before Placing a Bet [Yahoo! Finance]
3/21
08:06 am
anvs
Annovis Bio, Inc. (NYSE: ANVS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
High
Report
Annovis Bio, Inc. (NYSE: ANVS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
3/20
07:30 am
anvs
Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s Disease
High
Report
Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s Disease
8/14/2023
04:40 pm
anvs
annovis bio, inc.
BEAT
Report
-2.5%
annovis bio, inc.
5/10/2023
04:34 pm
anvs
annovis bio, inc.
MISS
Report
-0.1%
annovis bio, inc.
4/3
06:01 am
anvs
Form 8-K Annovis Bio, Inc. For: Apr 02
Medium
Report
Form 8-K Annovis Bio, Inc. For: Apr 02
3/29
05:13 pm
anvs
Form 10-K Annovis Bio, Inc. For: Dec 31
Low
Report
Form 10-K Annovis Bio, Inc. For: Dec 31
3/22
05:24 pm
anvs
Form 8-K Annovis Bio, Inc. For: Mar 22
Medium
Report
Form 8-K Annovis Bio, Inc. For: Mar 22
3/22
06:01 am
anvs
Form 424B5 Annovis Bio, Inc.
Medium
Report
Form 424B5 Annovis Bio, Inc.
3/21
05:24 pm
anvs
Form 8-K Annovis Bio, Inc. For: Mar 21
Medium
Report
Form 8-K Annovis Bio, Inc. For: Mar 21
3/20
04:44 pm
anvs
Form 8-K Annovis Bio, Inc. For: Mar 20
Medium
Report
Form 8-K Annovis Bio, Inc. For: Mar 20
3/20
06:02 am
anvs
Form 8-K Annovis Bio, Inc. For: Mar 19
High
Report
Form 8-K Annovis Bio, Inc. For: Mar 19
3/19
06:03 am
anvs
Form 424B5 Annovis Bio, Inc.
Low
Report
Form 424B5 Annovis Bio, Inc.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register